Robert Stone, CEO of City of Hope, recently highlighted the importance of leadership during challenging times at the Modern Healthcare Leadership Summit in Washington, D.C. He noted significant progress in cancer survival rates—over 70% of diagnosed individuals now live at least five years. However, he pointed out that nearly 40% of Americans will face a cancer diagnosis in their lifetime, with only 20% receiving treatment at NCI-designated cancer centers.
Stone emphasized that scientific advancements are only valuable if patients can access them, stressing the need for collaboration across industries and bringing expertise closer to communities. At City of Hope, the commitment is to ensure patients receive both top-tier science and compassionate care, aligning innovation with improved outcomes for a broader population.
For more insights from Robert Stone, visit his profile on OncoDaily.
